Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome

Hormone and Metabolic Research

Volumn 40, Issue 11, 2008, Pages 813-818

  Pall, M E ^b   Lao, M C ^b   Patel, S S ^b   Lee, M L ^a   Ghods, D E ^a   Chandler, D W ^c   Friedman, T C ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Esoterix Inc   (United States)

Author keywords

Androgens; Cushing's syndrome; Episodic; PCOS; Periodic; ROC; Testosterone

Indexed keywords

ANDROGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LABORATORY TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ANDROGENS; BIOLOGICAL AVAILABILITY; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIRSUTISM; HUMANS; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 57149104759     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1087186     Document Type: Article

References (36)

1. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006; 367: 1605-1617
2. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's syndrome. Lancet 2001; 357: 783-791
3. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998; 19: 647-672
4. Friedman TC, Zuckerbraun E, Lee ML, Kabil MS, Shahinian H. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup. Horm Metab Res 2007; 39: 451-456
5. Velez DA, Mayberg MR, Ludlam WH. Cyclic Cushing syndrome: definitions and treatment implications. Neurosurg Focus 2007; 23: E4 ; discussion E4a
6. Trivax B, Azziz R. Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol 2007; 50: 168-177
7. Friedman TC, Zuckerbraun E, Daigle K, Shahinian H. The changing face of Cushing's syndrome: mild and periodic cases makes the diagnosis more difficult. Endocrine Soc. (Abstract) 2004; 86: P3-408
8. Dronavalli S, Ehrmann DA. Pharmacologic therapy of polycystic ovary syndrome. Clin Obstet Gynecol 2007; 50: 244-254
9. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovarian syndrome: Towards a rational approach. In Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992; 377-384
10. Friedman TC. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism. Exp Clin Endocrinol Diabetes 2006; 114: 356-360
11. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr, Loriaux DL. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991; 325: 897-905
12. Friedman TC. Pseudo-Cushing syndrome. in Margioris AN, Chrousos GP, eds. Contemporary Endocrinology: Adrenal Disorders. Totowa, NJ: Humana Press; 2001; 203-218
13. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815-830
14. Foster LB, Dunn RT. Single-antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma. Clin Chem 1974; 20: 365-368
15. Papanicolaou DA, Yanovski JA, Cutler G Jr, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998; 83: 1163-1167
16. Burke CW. Biologically active cortisol in plasma of oestrogen-treated and normal subjects. Br Med J 1969; 2: 798-800
17. Doe RP, Zinneman HH, Flink HB, Ulstrom RA. Significance of the concentration of non protein bound plasma cortisol in normal subjects, Cushing's syndrome, pregnancy and during estrogen therapy. J Clin Endocrinol Metab 1960; 20: 1484-1492
18. Raff H, Homar PJ, Skoner DP. New enzyme immunoassay for salivary cortisol. Clin Chem 2003; 49: 203-204
19. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 1998; 83: 2681-2686
20. Silber RH, Porter CC. The determination of 17,21-dihydroxy-20- ketosteroids in urine and plasma. J Biol Chem 1954; 210: 923-932
21. Furuyama S, Mayes DM, Nugent CA. A radioimmunoassay for plasma testosterone. Steroids 1970; 16: 415-428
22. Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006; 91: 1683-1690
23. Mayes D, Nugent CA. Determination of plasma testosterone by the use of competitive protein binding. J Clin Endocrinol Metab 1968; 28: 1169-1176
24. Nankin HR, Pinto R, Fan DF, Troen P. Daytime titers of testosterone, LH, estrone, estradiol, and testosterone-binding protein: acute effects of LH and LH-releasing hormone in men. J Clin Endocrinol Metab 1975; 41: 271-281
25. Kapoor P, Luttrell BM, Williams D. The free androgen index is not valid for adult males. J Steroid Biochem Mol Biol 1993; 45: 325-326
26. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-298
27. Zhou X, Obuchowski N, MacClish D. Statistical Methods in Diagnostic Medicine. New York; 2002
28. Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin Endocrinol (Oxf) 2000; 53: 493-500
29. Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, Perry LA, Grossman AB, Besser GM, Trainer PJ. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab 1998; 83: 3083-3088
30. Karpas AE, Rodriguez-Rigau LJ, Smith KD, Steinberger E. Effect of acute and chronic androgen suppression by glucocorticoids on gonadotropin levels in hirsute women. J Clin Endocrinol Metab 1984; 59: 780-784
31. Odagiri E, Yamanaka V, Ishiwatari N, Jibiki K, Demura R, Demura H, Suda T, Shizume K. Studies on pituitary-gonadal function in patients with Cushing's syndrome. Endocrinol Jpn 1988; 35: 421-427
32. Anderson DC. The adrenal androgen-stimulating hormone does not exist. Lancet 1980; 2: 454-456
33. Cunningham SK, MacKenna TJ. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome. Clin Endocrinol (Oxf) 1994; 41: 795-800
34. Sinha-Hikim I, Arver S, Beall G, Shen R, Guerrero M, Sattler F, Shikuma C, Nelson JC, Landgren BM, Mazer NA, Bhasin S. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1998; 83: 1312-1318
35. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92: 405-413
36. Putignano P, Bertolini M, Losa M, Cavagnini F. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome. J Endocrinol Invest 2003; 26: 539-544